Jacob Grønnegaard of FujiFilm Diosynth Biotechnologies discussed how the company’s unique cloning processes dramatically reduce project execution time, effort and expense at Emerson Exchange Immerse event. The result is intended to be one of the top medicine production facilities in the country. Hopefully, it won’t have to ramp up production for a virus vaccine to combat a worldwide pandemic, but if the time ever comes again, it will be scalable and ready.
Latest News
Emerson’s New Laser Welder Automates Assembly of Small Plastic Parts with Complex Geometries
Branson GLX-1 platform offers automation-friendly solution for clean, vibration-free welding that supports closed-loop product recycling
Emerson Continues to Invest in Advanced NI Test & Measurement Products Featuring AI Tools
Emerson’s Test and Measurement business, formerly NI, today reaffirmed its commitment to its comprehensive test approach, unveiled significant...
Calvin Butler to Join Emerson’s Board of Directors
Emerson today announced the appointment of Calvin Butler to its Board of Directors, effective August 1, 2024.
